The strategic importance of mRNA vaccine technologies in Africa for achieving public health independence
To build mRNA vaccine manufacturing capacity in Africa, significant progress has been made in developing human, technical, and regulatory capacity.
Green Lipids – the next frontier for vaccine development
Emeritus Professor, Patrick Arbuthnot, of the Antiviral Gene Therapy Research Unit (AGTRU) at Wits University discusses the unit’s breakthrough innovation